Can a simple blood test predict cancer drug side effects?
NCT ID NCT07100054
First seen Jan 11, 2026 · Last updated May 12, 2026 · Updated 17 times
Summary
This study aims to find genetic and blood markers that can predict which breast cancer patients will have severe side effects or poor response to a class of drugs called kinase inhibitors. Researchers will analyze DNA and blood samples from 100 women with breast cancer who are taking CDK4/6 inhibitors. The goal is to create a model that helps doctors personalize treatment to reduce harm while keeping the drugs effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.